1. Home
  2. ADAP vs GTIM Comparison

ADAP vs GTIM Comparison

Compare ADAP & GTIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADAP
  • GTIM
  • Stock Information
  • Founded
  • ADAP 2008
  • GTIM 1987
  • Country
  • ADAP United Kingdom
  • GTIM United States
  • Employees
  • ADAP N/A
  • GTIM N/A
  • Industry
  • ADAP Biotechnology: Pharmaceutical Preparations
  • GTIM Restaurants
  • Sector
  • ADAP Health Care
  • GTIM Consumer Discretionary
  • Exchange
  • ADAP Nasdaq
  • GTIM Nasdaq
  • Market Cap
  • ADAP 21.3M
  • GTIM 17.1M
  • IPO Year
  • ADAP 2015
  • GTIM 1990
  • Fundamental
  • Price
  • ADAP $0.14
  • GTIM $1.63
  • Analyst Decision
  • ADAP Hold
  • GTIM
  • Analyst Count
  • ADAP 6
  • GTIM 0
  • Target Price
  • ADAP $1.02
  • GTIM N/A
  • AVG Volume (30 Days)
  • ADAP 139.0M
  • GTIM 15.0K
  • Earning Date
  • ADAP 11-12-2025
  • GTIM 08-07-2025
  • Dividend Yield
  • ADAP N/A
  • GTIM N/A
  • EPS Growth
  • ADAP N/A
  • GTIM 17.03
  • EPS
  • ADAP N/A
  • GTIM 0.12
  • Revenue
  • ADAP $65,084,999.00
  • GTIM $143,398,000.00
  • Revenue This Year
  • ADAP N/A
  • GTIM N/A
  • Revenue Next Year
  • ADAP $24.70
  • GTIM N/A
  • P/E Ratio
  • ADAP N/A
  • GTIM $13.91
  • Revenue Growth
  • ADAP N/A
  • GTIM 1.78
  • 52 Week Low
  • ADAP $0.04
  • GTIM $1.34
  • 52 Week High
  • ADAP $0.96
  • GTIM $3.00
  • Technical
  • Relative Strength Index (RSI)
  • ADAP 56.57
  • GTIM 49.99
  • Support Level
  • ADAP $0.12
  • GTIM $1.60
  • Resistance Level
  • ADAP $0.16
  • GTIM $1.66
  • Average True Range (ATR)
  • ADAP 0.03
  • GTIM 0.05
  • MACD
  • ADAP 0.00
  • GTIM 0.00
  • Stochastic Oscillator
  • ADAP 39.87
  • GTIM 61.51

About ADAP Adaptimmune Therapeutics plc

Adaptimmune Therapeutics PLC is a commercial-stage biopharmaceutical company working to redefine the treatment of solid tumor cancers with cell therapies. It has developed a comprehensive proprietary platform that enables it to identify cancer targets, find and genetically engineer T-cell receptors, and produce TCR therapeutic candidates for administration to patients. Its programs include MAGE-A4 SPEAR T-cell therapy, NY-ESO SPEAR T-cell, CD70, and others for multiple cancer types.

About GTIM Good Times Restaurants Inc.

Good Times Restaurants Inc is engaged in developing, owning, operating, and franchising hamburger-oriented drive-through restaurants. It operates through two segments: Good Times Burgers and Frozen Custard restaurants which operate in the quick-service drive-through dining industry; and Bad Daddy's Burger Bar restaurants which operate in the full-service upscale casual dining industry. The company generates maximum revenue from the Bad Daddy's Burger Bar restaurants segment. Its menu categories include burgers; chicken; frozen custard; slides and drinks.

Share on Social Networks: